Abryl Formulations Private Limited, a active foreign private limited company, was established on 23 August 2006 in Bathinda, Punjab, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24239PB2006FTC030567. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.90 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Its leadership includes Neerja Singla (Director), Aditya Singla (Director), Sanjeev Agnihotri (Director). Past directors included Simmi Singla, Pushpa Rani, Ranjana Rajput. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 17406A, Street No. 3 Minocha Colony, Bathinda, Punjab, 151001.
U24239PB2006FTC030567
030567
23 August 2006
₹0.90 M
₹0.90 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Abryl Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neerja Singla | Director | 23 Aug 2006 | Current |
| Aditya Singla | Director | 20 Aug 2024 | Current |
| Sanjeev Agnihotri | Director | 11 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Aug 2024 | Past |
| Pramod Abcsdd | Director | 24 Aug 2018 | Past |
| Pramod Abcsdd | Director | 10 May 2010 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abryl Formulations Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 2.48% increase. The company also saw a substantial improvement in profitability, with a 11.39% increase in profit. The company's net worth Soared by an impressive increase of 18.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Abryl Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Abryl Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Abryl Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abryl Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sanjeev Agnihotri was appointed as a Director was appointed as a Director on 11 Oct 2025 & has been associated with this company since 1 month 13 days . was recorded as a recent event.
Progress on Abryl Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Aditya Singla was appointed as a Director was appointed as a Director on 20 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
The activity Abryl Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Neerja Singla was appointed as a Director was appointed as a Director on 23 Aug 2006 & has been associated with this company since 19 years 3 months . was recorded as a recent event.
Progress on Abryl Formulations Private Limited was registered on 23 Aug 2006 with Roc Chandigarh & aged 19 years 3 months as per MCA records. was documented.
The CIN of Abryl Formulations Private Limited is U24239PB2006FTC030567.
Abryl Formulations Private Limited is headquartered at 17406A, Street No. 3 Minocha Colony, Bathinda, Punjab, 151001.
Abryl Formulations Private Limited was incorporated on 23 August 2006.
The current directors of Abryl Formulations Private Limited are
The primary industry of Abryl Formulations Private Limited is Professional, Scientific And Technical.
Abryl Formulations Private Limited is unlisted.
The authorized capital of Abryl Formulations Private Limited is ₹0.90 M, and the paid-up capital is ₹0.90 M.
The compliance status of Abryl Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX